USANA Health Sciences
12
0
0
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 12 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
22%
2 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Safety and Tolerability of 2 Dietary Supplement Beverages Designed to Maintain Healthy Blood Pressure.
Role: lead
Active Nutrition Program on Weight Loss
Role: collaborator
A Follow-up Trial of Proglucamune® in the Treatment of Protective Qi Deficiency, a TCM Condition
Role: lead
The Acute Effects of a Dietary Supplement on Cognitive Performance in Highly Trained Athletes.
Role: lead
A Clinical Study to Determine if Beta Glucan Reduces the Incidence, Duration or Severity of URTIs Among Skiers
Role: lead
The Effects of an Oral Probiotic Intervention With or Without a Novel ADP-1 Toothpaste
Role: lead
Impact of Jump Start Nutrition Program on Weight Loss and Associated Measures
Role: collaborator
An Evaluation of Proglucamune in the Treatment of Protective Qi Insufficiency
Role: lead
Vitamin D Supplementation in Knee Osteoarthritis
Role: collaborator
Effect of a MVM Dietary Supplement on Indices of Human Health
Role: lead
Effect of a Multivitamin/Multimineral/Phytochemical Dietary Supplement on Indices of Human Health
Role: lead
Effects of Dietary Supplements on Response to Air Pollution
Role: collaborator
All 12 trials loaded